Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secukinumab with OCT monitoring in plaque psoriasis
NCT03307447Phase 4Unknown
- Sponsor
- Narrows Institute for Biomedical Research
- Start
- Dec 2017
- Primary completion
- Sep 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of secukinumab in plaque psoriasis, sponsored by Narrows Institute for Biomedical Research. Status: unknown.
02
Drugs
secukinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03307447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03307447.